FDA.reportPublic FDA data

CYTARABINE

Substance profile for UNII 04079A1RDZ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CYTARABINE
Structure render from PubChem CID 6253

Substance Identity#

UNII
04079A1RDZ
Preferred term
CYTARABINE
Registry number
147-94-4
EC number
205-705-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C9H13N3O5
Chemical structure for CYTARABINE
Structure render from PubChem CID 6253

Chemical And Database Identifiers#

InChIKey
UHDGCWIWMRVCDJ-CCXZUQQUSA-N
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
RxCUI
3041
PubChem
6253
NCIt
C408
INN ID
1709

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound6253https://pubchem.ncbi.nlm.nih.gov/compound/6253
PubChem InChIKey SearchUHDGCWIWMRVCDJ-CCXZUQQUSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=UHDGCWIWMRVCDJ-CCXZUQQUSA-N
RxNorm3041https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3041
NCI ThesaurusC408https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C408
FDA Substance Registration System04079A1RDZhttps://precision.fda.gov/uniisearch/srs/unii/04079A1RDZ
European Community number205-705-9https://commonchemistry.cas.org/results?q=205-705-9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
CYTARABINEACTIVE MOIETY04079A1RDZDEPOCYT (CYTARABINE) INJECTION, LIPID COMPLEX [SIGMA-TAU PHARMACEUTICALS, INC.]8
CYTARABINEACTIVE INGREDIENT04079A1RDZDEPOCYT (CYTARABINE) INJECTION, LIPID COMPLEX [SIGMA-TAU PHARMACEUTICALS, INC.]8
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]5
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]5
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]2
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]2
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]1
CYTARABINEACTIVE MOIETY04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]1
CYTARABINEACTIVE INGREDIENT04079A1RDZCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]1